Expion360 heads into the aftermath of its Q1 results with short sellers already in full retreat — yet the stock is still falling.
The defining tension this week is the disconnect between positioning and price. Short interest collapsed 56% over the past week, dropping from roughly 1.8% of float to 0.8%. That is a sharp exit from a position that was never crowded in absolute terms — the absolute float percentage was too small to classify as a major short thesis. But the speed of the exit is notable. Shares on loan fell from around 175,000 in early May to under 78,000 by May 14. Whatever shorts were in the name, they covered aggressively — and yet the stock still shed 8% on the week to close at $0.59, near the bottom of its three-month range of $0.49–$0.83.
The lending market reflects the lighter positioning. Availability has loosened as shorts returned borrowed shares, and borrow costs have eased to 13.2% — down from a recent peak above 15% in early April and off about 8% over the past month. With the lending pool now far less utilised than it was in mid-April (when utilisation ran above 37%), there is no sign of squeeze dynamics. The ORTEX short score has also declined meaningfully, dropping from 47.5 on May 4 to 39.7 by May 14 — confirming the trend away from aggressive short positioning.
The catalyst for the covering is now clear: reported Q1 2026 results on May 15. Revenue came in at $1.57 million, down from $2.05 million a year earlier. EPS of -$0.17 improved from -$0.37 year-over-year — a meaningful reduction in losses, but set against a sharp revenue decline. The earnings history suggests a volatile stock around results: the April 2026 event produced a +12% one-day move and a +22% five-day move, while the November 2025 print delivered a -8.7% day-one loss and extended to -20% over five days. With the stock down on the week into and through the print, the market's immediate verdict on the Q1 numbers appears cautious.
Next week brings the next scheduled event on May 21. With short interest now at multi-month lows, borrow costs drifting down, and correlated peers broadly under pressure — ENVX fell 7.6% on the week, SMR dropped 10.5%, and NNE was off 9.2% — the question is whether the Q1 revenue miss reopens bearish positioning or whether reduced loss depth attracts buyers at the $0.59 level.
See the live data behind this article on ORTEX.
Open XPON on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
